Which has higher earnings and valuation, ECOR or CV?

electroCore has higher revenue and earnings than CapsoVision. CapsoVision is trading at a lower price-to-earnings ratio than electroCore, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio electroCore $36.97M 2.79 -$13.97M -$1.66 N/A CapsoVision $13.89M 21.80 -$25.32M -$0.47 N/A

Is ECOR or CV more profitable?

electroCore has a net margin of -39.96% compared to CapsoVision's net margin of -214.74%. CapsoVision's return on equity of -177.85% beat electroCore's return on equity. Company Net Margins Return on Equity Return on Assets electroCore -39.96% -1,956.38% -81.35% CapsoVision -214.74% -177.85% -135.07%

Does the media refer more to ECOR or CV?

In the previous week, CapsoVision had 7 more articles in the media than electroCore. MarketBeat recorded 11 mentions for CapsoVision and 4 mentions for electroCore. electroCore's average media sentiment score of 1.45 beat CapsoVision's score of 1.33 indicating that electroCore is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment electroCore 2 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive CapsoVision 6 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Is ECOR or RCEL more profitable?

electroCore has a net margin of -39.96% compared to Avita Medical's net margin of -56.96%. Avita Medical's return on equity of 0.00% beat electroCore's return on equity. Company Net Margins Return on Equity Return on Assets electroCore -39.96% -1,956.38% -81.35% Avita Medical -56.96% N/A -78.53%

Does the media refer more to ECOR or TMCI?

In the previous week, Treace Medical Concepts had 3 more articles in the media than electroCore. MarketBeat recorded 7 mentions for Treace Medical Concepts and 4 mentions for electroCore. electroCore's average media sentiment score of 1.45 beat Treace Medical Concepts' score of 0.78 indicating that electroCore is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment electroCore 2 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Treace Medical Concepts 4 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media prefer TLSI or ECOR?

In the previous week, TriSalus Life Sciences had 7 more articles in the media than electroCore. MarketBeat recorded 11 mentions for TriSalus Life Sciences and 4 mentions for electroCore. electroCore's average media sentiment score of 1.45 beat TriSalus Life Sciences' score of 0.60 indicating that electroCore is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment TriSalus Life Sciences 3 Very Positive mention(s) 4 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive electroCore 2 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

electroCore (ECOR) Competitors

$11.42 -0.87 (-7.08%)

Closing price 09/23/2026 04:00 PM Eastern

Extended Trading

$11.60 +0.18 (+1.53%)

As of 04:02 AM Eastern

Compare

ECOR vs. MOBI, CV, RCEL, TMCI, and TLSI

Should you buy electroCore stock or one of its competitors? electroCore's main competitors and comparable companies include Mobia Medical (MOBI), CapsoVision (CV), Avita Medical (RCEL), Treace Medical Concepts (TMCI), and TriSalus Life Sciences (TLSI). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare equipment" industry.

How does electroCore compare to Mobia Medical?

electroCore (NASDAQ:ECOR) and Mobia Medical (NASDAQ:MOBI) are both small-cap healthcare companies, but which is the better business? We will contrast the two businesses based on the strength of their dividends, risk, profitability, institutional ownership, media sentiment, valuation, earnings and analyst recommendations.

26.7% of electroCore shares are owned by institutional investors. 7.8% of electroCore shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

In the previous week, electroCore had 4 more articles in the media than Mobia Medical. MarketBeat recorded 4 mentions for electroCore and 0 mentions for Mobia Medical. electroCore's average media sentiment score of 1.45 beat Mobia Medical's score of 0.00 indicating that electroCore is being referred to more favorably in the media.

Company	Overall Sentiment
electroCore	Positive
Mobia Medical	Neutral

electroCore presently has a consensus price target of $18.00, indicating a potential upside of 57.62%. Mobia Medical has a consensus price target of $20.75, indicating a potential upside of 126.53%. Given Mobia Medical's stronger consensus rating and higher possible upside, analysts plainly believe Mobia Medical is more favorable than electroCore.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
electroCore	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Mobia Medical	1 Sell rating(s)	1 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.57

Mobia Medical has a net margin of 0.00% compared to electroCore's net margin of -39.96%. Mobia Medical's return on equity of 0.00% beat electroCore's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
electroCore	-39.96%	-1,956.38%	-81.35%
Mobia Medical	N/A	N/A	N/A

electroCore has higher earnings, but lower revenue than Mobia Medical. electroCore is trading at a lower price-to-earnings ratio than Mobia Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
electroCore	$36.97M	2.79	-$13.97M	-$1.66	N/A
Mobia Medical	$45.28M	6.73	-$46.50M	-$20.18	N/A

Summary

Mobia Medical beats electroCore on 9 of the 15 factors compared between the two stocks.

How does electroCore compare to CapsoVision?

electroCore (NASDAQ:ECOR) and CapsoVision (NASDAQ:CV) are both small-cap healthcare companies, but which is the superior investment? We will contrast the two companies based on the strength of their media sentiment, profitability, dividends, institutional ownership, earnings, analyst recommendations, valuation and risk.

electroCore currently has a consensus target price of $18.00, indicating a potential upside of 57.62%. CapsoVision has a consensus target price of $9.50, indicating a potential upside of 57.02%. Given electroCore's higher probable upside, research analysts clearly believe electroCore is more favorable than CapsoVision.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
electroCore	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
CapsoVision	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.25

26.7% of electroCore shares are owned by institutional investors. 7.8% of electroCore shares are owned by company insiders. Comparatively, 2.3% of CapsoVision shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

electroCore has a beta of 1, meaning that its stock price has a similar volatility profile to the broader market.Comparatively, CapsoVision has a beta of -2.47, meaning that its stock price is 347% less volatile than the broader market.

In the previous week, CapsoVision had 7 more articles in the media than electroCore. MarketBeat recorded 11 mentions for CapsoVision and 4 mentions for electroCore. electroCore's average media sentiment score of 1.45 beat CapsoVision's score of 1.33 indicating that electroCore is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
electroCore	2 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
CapsoVision	6 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

electroCore has a net margin of -39.96% compared to CapsoVision's net margin of -214.74%. CapsoVision's return on equity of -177.85% beat electroCore's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
electroCore	-39.96%	-1,956.38%	-81.35%
CapsoVision	-214.74%	-177.85%	-135.07%

electroCore has higher revenue and earnings than CapsoVision. CapsoVision is trading at a lower price-to-earnings ratio than electroCore, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
electroCore	$36.97M	2.79	-$13.97M	-$1.66	N/A
CapsoVision	$13.89M	21.80	-$25.32M	-$0.47	N/A

Summary

electroCore beats CapsoVision on 10 of the 16 factors compared between the two stocks.

How does electroCore compare to Avita Medical?

electroCore (NASDAQ:ECOR) and Avita Medical (NASDAQ:RCEL) are both small-cap healthcare companies, but which is the superior investment? We will compare the two businesses based on the strength of their earnings, media sentiment, risk, dividends, profitability, analyst recommendations, institutional ownership and valuation.

In the previous week, electroCore had 4 more articles in the media than Avita Medical. MarketBeat recorded 4 mentions for electroCore and 0 mentions for Avita Medical. electroCore's average media sentiment score of 1.45 beat Avita Medical's score of 0.00 indicating that electroCore is being referred to more favorably in the media.

Company	Overall Sentiment
electroCore	Positive
Avita Medical	Neutral

electroCore has a net margin of -39.96% compared to Avita Medical's net margin of -56.96%. Avita Medical's return on equity of 0.00% beat electroCore's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
electroCore	-39.96%	-1,956.38%	-81.35%
Avita Medical	-56.96%	N/A	-78.53%

electroCore has higher earnings, but lower revenue than Avita Medical. Avita Medical is trading at a lower price-to-earnings ratio than electroCore, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
electroCore	$36.97M	2.79	-$13.97M	-$1.66	N/A
Avita Medical	$75.63M	4.46	-$48.59M	-$1.44	N/A

electroCore has a beta of 1, indicating that its share price has a similar volatility profile to the broader market.Comparatively, Avita Medical has a beta of 2.02, indicating that its share price is 102% more volatile than the broader market.

electroCore currently has a consensus target price of $18.00, indicating a potential upside of 57.62%. Avita Medical has a consensus target price of $11.40, indicating a potential upside of 4.11%. Given electroCore's higher probable upside, research analysts clearly believe electroCore is more favorable than Avita Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
electroCore	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Avita Medical	1 Sell rating(s)	1 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.57

26.7% of electroCore shares are owned by institutional investors. Comparatively, 27.7% of Avita Medical shares are owned by institutional investors. 7.8% of electroCore shares are owned by company insiders. Comparatively, 2.2% of Avita Medical shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Summary

Avita Medical beats electroCore on 9 of the 16 factors compared between the two stocks.

How does electroCore compare to Treace Medical Concepts?

electroCore (NASDAQ:ECOR) and Treace Medical Concepts (NASDAQ:TMCI) are both small-cap healthcare companies, but which is the superior investment? We will compare the two businesses based on the strength of their dividends, profitability, analyst recommendations, institutional ownership, earnings, valuation, risk and media sentiment.

Treace Medical Concepts has a net margin of -28.99% compared to electroCore's net margin of -39.96%. Treace Medical Concepts' return on equity of -71.37% beat electroCore's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
electroCore	-39.96%	-1,956.38%	-81.35%
Treace Medical Concepts	-28.99%	-71.37%	-30.49%

electroCore presently has a consensus price target of $18.00, suggesting a potential upside of 57.62%. Treace Medical Concepts has a consensus price target of $5.17, suggesting a potential upside of 14.63%. Given electroCore's stronger consensus rating and higher probable upside, analysts clearly believe electroCore is more favorable than Treace Medical Concepts.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
electroCore	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Treace Medical Concepts	2 Sell rating(s)	4 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	1.86

electroCore has higher earnings, but lower revenue than Treace Medical Concepts. electroCore is trading at a lower price-to-earnings ratio than Treace Medical Concepts, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
electroCore	$36.97M	2.79	-$13.97M	-$1.66	N/A
Treace Medical Concepts	$212.69M	1.38	-$59M	-$0.93	N/A

26.7% of electroCore shares are held by institutional investors. Comparatively, 84.1% of Treace Medical Concepts shares are held by institutional investors. 7.8% of electroCore shares are held by company insiders. Comparatively, 23.4% of Treace Medical Concepts shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

electroCore has a beta of 1, indicating that its stock price has a similar volatility profile to the broader market.Comparatively, Treace Medical Concepts has a beta of 1.4, indicating that its stock price is 40% more volatile than the broader market.

In the previous week, Treace Medical Concepts had 3 more articles in the media than electroCore. MarketBeat recorded 7 mentions for Treace Medical Concepts and 4 mentions for electroCore. electroCore's average media sentiment score of 1.45 beat Treace Medical Concepts' score of 0.78 indicating that electroCore is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
electroCore	2 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Treace Medical Concepts	4 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Treace Medical Concepts beats electroCore on 10 of the 15 factors compared between the two stocks.

How does electroCore compare to TriSalus Life Sciences?

TriSalus Life Sciences (NASDAQ:TLSI) and electroCore (NASDAQ:ECOR) are both small-cap healthcare companies, but which is the superior stock? We will contrast the two companies based on the strength of their risk, earnings, dividends, profitability, valuation, analyst recommendations, institutional ownership and media sentiment.

2.6% of TriSalus Life Sciences shares are owned by institutional investors. Comparatively, 26.7% of electroCore shares are owned by institutional investors. 16.3% of TriSalus Life Sciences shares are owned by company insiders. Comparatively, 7.8% of electroCore shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

In the previous week, TriSalus Life Sciences had 7 more articles in the media than electroCore. MarketBeat recorded 11 mentions for TriSalus Life Sciences and 4 mentions for electroCore. electroCore's average media sentiment score of 1.45 beat TriSalus Life Sciences' score of 0.60 indicating that electroCore is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
TriSalus Life Sciences	3 Very Positive mention(s)	4 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
electroCore	2 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

TriSalus Life Sciences has a beta of 0.44, indicating that its stock price is 56% less volatile than the broader market. Comparatively, electroCore has a beta of 1, indicating that its stock price has a similar volatility profile to the broader market.

TriSalus Life Sciences currently has a consensus price target of $10.20, indicating a potential upside of 104.00%. electroCore has a consensus price target of $18.00, indicating a potential upside of 57.62%. Given TriSalus Life Sciences' stronger consensus rating and higher probable upside, equities analysts clearly believe TriSalus Life Sciences is more favorable than electroCore.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
TriSalus Life Sciences	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40
electroCore	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

electroCore has a net margin of -39.96% compared to TriSalus Life Sciences' net margin of -62.59%. TriSalus Life Sciences' return on equity of 0.00% beat electroCore's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
TriSalus Life Sciences	-62.59%	N/A	-64.47%
electroCore	-39.96%	-1,956.38%	-81.35%

electroCore has lower revenue, but higher earnings than TriSalus Life Sciences. electroCore is trading at a lower price-to-earnings ratio than TriSalus Life Sciences, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
TriSalus Life Sciences	$45.15M	6.82	-$39.23M	-$1.30	N/A
electroCore	$36.97M	2.79	-$13.97M	-$1.66	N/A

Summary

TriSalus Life Sciences beats electroCore on 11 of the 16 factors compared between the two stocks.

Get electroCore News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ECOR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

ECOR vs. The Competition

Export

Metric	electroCore	Healthcare Equipment & Supplies Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$110.81M	$5.58B	$7.31B	$13.29B
Dividend Yield	N/A	1.79%	2.52%	12.57%
P/E Ratio	-6.88	25.26	274.08	25.69
Price / Sales	2.79	71.56	638.21	78.99
Price / Cash	N/A	33.02	77.80	52.76
Price / Book	-54.38	5.78	10.47	6.32
Net Income	-$13.97M	$151.55M	$3.49B	$359.73M
7 Day Performance	0.35%	-0.01%	-0.67%	0.17%
1 Month Performance	18.34%	-3.53%	-3.17%	-3.27%
1 Year Performance	121.75%	6.37%	15.14%	5.58%

electroCore Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
ECOR electroCore	3.1619 of 5 stars	$11.42 -7.1%	$18.00 +57.6%	+120.9%	$110.81M	$36.97M	N/A	83	News Coverage Positive News Analyst Forecast Gap Down
MOBI Mobia Medical	3.7721 of 5 stars	$10.77 +7.4%	$20.75 +92.7%	N/A	$333.91M	$32.04M	N/A	167
CV CapsoVision	3.4758 of 5 stars	$6.38 -2.0%	$9.50 +48.9%	+32.4%	$325.80M	$13.55M	N/A	99	News Coverage Positive News Insider Trade High Trading Volume
RCEL Avita Medical	0.927 of 5 stars	$10.21 +0.2%	$11.40 +11.7%	+100.9%	$313.61M	$71.61M	N/A	226	Analyst Forecast
TMCI Treace Medical Concepts	2.9018 of 5 stars	$4.58 -1.1%	$5.17 +12.9%	-33.7%	$301.11M	$212.69M	N/A	450

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:ECOR) was last updated on 9/24/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

electroCore (ECOR) Competitors

ECOR vs. MOBI, CV, RCEL, TMCI, and TLSI

How does electroCore compare to Mobia Medical?

Summary

How does electroCore compare to CapsoVision?

Summary

How does electroCore compare to Avita Medical?

Summary

How does electroCore compare to Treace Medical Concepts?

Summary

How does electroCore compare to TriSalus Life Sciences?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ECOR vs. The Competition

electroCore Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

electroCore (ECOR) Competitors

ECOR vs. MOBI, CV, RCEL, TMCI, and TLSI

How does electroCore compare to Mobia Medical?

Do insiders & institutionals believe in ECOR or MOBI?

Does the media favor ECOR or MOBI?

Do analysts recommend ECOR or MOBI?

Is ECOR or MOBI more profitable?

Which has better earnings & valuation, ECOR or MOBI?

Summary

How does electroCore compare to CapsoVision?

Do analysts recommend ECOR or CV?

Do insiders and institutionals believe in ECOR or CV?

Which has more volatility & risk, ECOR or CV?

Does the media refer more to ECOR or CV?

Is ECOR or CV more profitable?

Which has higher earnings and valuation, ECOR or CV?

Summary

How does electroCore compare to Avita Medical?

Does the media refer more to ECOR or RCEL?

Is ECOR or RCEL more profitable?

Which has higher earnings & valuation, ECOR or RCEL?

Which has more volatility & risk, ECOR or RCEL?

Do analysts rate ECOR or RCEL?

Do insiders & institutionals hold more shares of ECOR or RCEL?

Summary

How does electroCore compare to Treace Medical Concepts?

Is ECOR or TMCI more profitable?

Do analysts rate ECOR or TMCI?

Which has stronger earnings & valuation, ECOR or TMCI?

Do insiders and institutionals have more ownership in ECOR or TMCI?

Which has more volatility and risk, ECOR or TMCI?

Does the media refer more to ECOR or TMCI?

Summary

How does electroCore compare to TriSalus Life Sciences?

Do insiders & institutionals believe in TLSI or ECOR?

Does the media prefer TLSI or ECOR?

Which has more volatility & risk, TLSI or ECOR?

Do analysts recommend TLSI or ECOR?

Is TLSI or ECOR more profitable?

Which has better earnings & valuation, TLSI or ECOR?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ECOR vs. The Competition

electroCore Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools